Last updated: 2026-09-18 15:00:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $268,70, with a market capitalization of $644,12B and a P/E ratio of 30,96. Over the past 52 weeks, its price has ranged from $173,33 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$644,12B | |
$269,45 | |
$281,07 | |
$46,25 | |
$270,22 | |
2,31M | |
7,53M | |
30,96 | |
$281,07 | |
$173,33 | |
1,94% | |
-- |
Johnson & Johnson (JNJ) is currently trading at $268,70 as of 2026-09-18 14:44:59, down 0,56% ($1,52) from the previous close of $270,22
During today's regular trading session, JNJ has traded between $46,25 and $281,07, with a trading volume of 2,31M shares. The current price is near the upper end of today's range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $267,08 to $268,70, representing a gain of 0,61% ($1,62).
The stock traded between $260,68 and $271,55 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 5,32 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 88,5%
JNJ is currently trading at $268,70, placing it 88,5% of the way from its 52-week low of $173,33 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.